Examples Finance Innovation Pharmaceuticals 
Strategy Driven
JULY 13, 2011
Value: The Four Cornerstones of Corporate Finance by Tim Koller. While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Discusses the four foundational principles of corporate finance.
Harvard Business Review
JUNE 29, 2015
And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
OCTOBER 26, 2011
A star example is Google, which raised a mere $40 million in private funding before its IPO at a $23 billion valuation. Examples like Amyris, Solazyme, Gevo, and KiOR have opened the door for other companies to file. Even if most of their investments fail, a few spectacular successes can "make the fund" for a VC.
Harvard Business Review
MARCH 14, 2017
For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. Yet they have already generated tens of millions of dollars in value for Roivant.
Harvard Business Review
APRIL 2, 2018
Examples of significant investments in low-value care services abound in the U.S. For example, a cardiologist who performs and reads nuclear stress tests, which are frequently low value , has the ability to order these studies for his or her patient.) So if we want to see better outcomes, we need to start to think like investors.
Harvard Business Review
JUNE 9, 2017
How the most innovative providers are creating value. Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. Insight Center. The Leading Edge of Health Care.
Harvard Business Review
OCTOBER 13, 2011
The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Here, the protocols from other industries can provide some insight.
Expert insights. Personalized for you.
62 
Let's personalize your content